>>>welcome visitor, haven't logged in. Login
Subscribe Now Contact us  
Font Size:  A A A Search “Fabao” Window English 中文 = 简体  繁体
  Favorite   DownLoad   Print
 
Announcement No. 88 [2016] of the Ministry of Commerce -- Announcement on Decisions from Anti-monopoly Review of the Concentration of Undertakings on Conditional Approval of Proposed Acquisition of Equity in St. Jude Medical by Abbott [Effective]
商务部公告2016年第88号――关于附加限制性条件批准雅培公司收购圣犹达医疗公司股权案经营者集中反垄断审查决定的公告 [现行有效]
【法宝引证码】

Announcement of the Ministry of Commerce 

商务部公告

(No. 88 [2016]) (2016年第88号)

Announcement on Decisions from Anti-monopoly Review of the Concentration of Undertakings on Conditional Approval of Proposed Acquisition of Equity in St. Jude Medical by Abbott 关于附加限制性条件批准雅培公司收购圣犹达医疗公司股权案经营者集中反垄断审查决定的公告
The Ministry of Commerce of the People's Republic of China (hereinafter referred to as the ‘Ministry of Commerce') received the anti-monopoly declaration of the concentration of undertakings on the case of the acquisition of equity in St. Jude Medical Inc. (hereinafter referred to as ‘St. Jude Medical') by Abbott (hereinafter referred to as the ‘Case'). Upon review, the Ministry of Commerce decided to approve the concentration of undertakings with additional restrictive conditions. In accordance with Article 30 of the Anti-monopoly Law of the People's Republic of China (hereinafter referred to as the ‘Anti-monopoly Law'), relevant matters are hereby announced as follows: 中华人民共和国商务部(以下简称商务部)收到雅培公司(以下简称雅培)收购圣犹达医疗公司(以下简称圣犹达)股权案(以下简称本案)的经营者集中反垄断申报。经审查,商务部决定附加限制性条件批准此项经营者集中。根据《中华人民共和国反垄断法》(以下简称《反垄断法》)第三十条,现公告如下:
I. Case-filing and review procedures   一、立案和审查程序
On July 4th, 2016, the Ministry of Commerce received the anti-monopoly declaration for the concentration of undertakings concerning the Case. Upon review, the Ministry of Commerce considered that the documents for declaration were incomplete, and required the declarer to conduct supplementation. On September 6th, after further supplementation, the Ministry of Commerce confirmed that the documents and materials complied with Article 23 of the Anti-monopoly Law, and therefore the anti-monopoly declaration for the concentration of undertakings was admitted to be filed, and the preliminary investigation was launched. On October 6th, the Ministry of Commerce decided to further review this concentration of undertakings. Upon review, the Ministry of Commerce considered that the concentration might have the effects of eliminating and restricting competition in the market of small vascular closure devices in China. The Case is currently under review. The deadline is January 4th, 2017. 2016年7月4日,商务部收到本案的经营者集中申报。经审核,商务部认为该申报材料不完备,要求申报方予以补充。9月6日,商务部确认经补充的申报材料符合《反垄断法》二十三条规定,对此项经营者集中申报予以立案并开始初步审查。10月6日,商务部决定对此项经营者集中实施进一步审查。经进一步审查,商务部认为,此项集中对中国小腔血管闭合器市场具有排除、限制竞争的效果。目前处于进一步审查阶段,截止日期为2017年1月4日。
In the course of the review, the Ministry of Commerce solicited opinions from relevant government departments, trade associations and industry experts, and reviewed the authenticity, completeness and accuracy of the documents and materials submitted by the declarer. 在审查过程中,商务部征求了有关政府部门、行业协会及行业专家意见,对申报方提交的申报材料的真实性、完整性和准确性进行了审核。
II. General information of the Case   二、案件基本情况
Abbott, the acquirer, which was founded in 1900, is a global healthcare company based in Illinois, America. It is mainly engaged in drugs, nourishment, medical devices and diagnostic services. 收购方雅培设立于1900年,是一家全球性医疗保健公司,总部位于美国伊利诺伊州,主要从事药品、营养品、医疗器械以及诊断等业务。
St. Jude Medical, the acquiree, which was founded in 1976, is a global medical device company based in Minnesota, America. It is mainly engaged in cardiovascular medical devices and other business. 被收购方圣犹达设立于1976年,是一家全球性医疗器械公司,总部位于美国明尼苏达州,主要从事心血管医疗器械等业务。
On April 27th, 2016, Abbott and St. Jude Medical concluded the Merger Agreement, specifying that Abbott will purchase all the equity in St. Jude Medical. Upon the transaction, St. Jude Medical will become a wholly-owned subsidiary of Abbott. 2016年4月27日,雅培和圣犹达签署了《并购协议》,雅培将收购圣犹达全部股份。交易完成后,圣犹达将成为雅培公司的全资子公司。
III. Relevant markets   三、相关市场
(1) Relevant commodity markets. (一)相关商品市场。
After reviewing all the products that Abbott and St. Jude Medical are selling in the Chinese market, the Ministry of Commerce found that Abbott and St. Jude Medical laterally overlap only in small vascular closure devices. 在审核雅培和圣犹达在中国市场所销售的全部产品后,商务部发现,雅培和圣犹达在中国市场唯一存在横向重叠的产品为小腔血管闭合器。
Vascular closure means that in the minimally invasive diagnosis and intervention of cardiovascular surgery, the blood vessel puncture point will produce a cavity, and this cavity must be closed after surgery to prevent blood loss. In general, vascular closure can be achieved in four ways: artificial compression, closed assist devices, surgical sutures and vascular closure devices. A vascular closure device is a disposable medical device for closing the lumen of the blood vessel. By injecting the occlusion of the lumen (such as a collagen anchor) into the blood vessel, it temporarily blocks the vascular cavity with the umbrella design in its front; at the same time, by using the elastic retraction of the arterial wall, the lumen of the blood vessel is reduced, the umbrella occluder in the front end is left in the sub-layer of the vascular wall, and a seal tightly fits the puncture point in the vascular cavity; a little pressure at this point on the outside can achieve the effect of closing the blood vessels. The use of vascular closure devices significantly reduces the length of postoperative bed and hospital stay, improves patient comfort, significantly reduces the incidence of vascular complications and venous thrombosis, and is significantly different from other vascular closure methods. The vascular closure device is bound by a closed diameter 8F (1F=1/3 mm) vascular cavity, and divided into the large cavity vascular closure device and small vascular closure device. The small vascular closure device is defined as a vascular closure device less than or equal to 8F, and neither can be substituted for the other. There is only lateral overlap in the bilateral concentration of the small vascular closure device market. Therefore, the case defined the small vascular closure device as the relevant product market.
......
 血管闭合是指在心血管微创诊断和介入手术中,血管穿刺点会产生腔孔,手术完成后必须闭合此腔孔以防止失血。通常情况下,血管闭合可以通过四种方式来实现,分别为人工压迫、闭合辅助器械、外科缝合以及血管闭合器。血管闭合器是用来闭合血管腔孔的一次性使用的医疗器械,通过将血管腔孔封堵物(如胶原锚)注射进血管内,利用其前端的伞形设计,暂时封堵住血管腔孔,同时利用动脉血管壁的弹性回缩作用,使血管腔孔缩小,前端的伞状封堵物被留在血管壁下层,并紧紧贴合在血管腔孔处以封住穿刺点,此时在体外稍加压迫即可达到闭合血管的效果。血管闭合器的使用显著缩短了术后卧床和住院时间,提高了患者的舒适度,并显著降低了血管并发症和静脉血栓的形成几率,与其他血管闭合方式具有明显不同。血管闭合器又以闭合直径8F(1F=1/3毫米)血管腔孔为界,分为大腔血管闭合器和小腔血管闭合器,其中小于或等于8F的血管闭合器为小腔血管闭合器,两者不可替代。集中双方仅在小腔血管闭合器市场存在横向重叠。因此,本案将小腔血管闭合器界定为相关商品市场。
......

Dear visitor, as a premium member of this database, you will get complete access to all content.Please go premium and get more.

1. To become a premium member, please call 400-810-8266 Ext. 171.

2. Binding to the account with access to this database.

3. Apply for a trial account.

4. To get instant access to a document, you can Pay Amount 【¥400.00】 for your single purchase.
 
您好:您现在要进入的是北大法宝英文库会员专区。
如您是我们英文用户可直接 登录,进入会员专区查询您所需要的信息;如您还不是我们 的英文用户;您可通过网上支付进行单篇购买,支付成功后即可立即查看本篇内容。
Tel: +86 (10) 82689699, +86 (10) 82668266 ext. 153
Mobile: +86 13311570713
Fax: +86 (10) 82668268
E-mail:info@chinalawinfo.com
     
     
Scan QR Code and Read on Mobile
【法宝引证码】        北大法宝en.pkulaw.cn
Message: Please kindly comment on the present translation.
 
Confirmation Code:
Click image to reset code
 
  Translations are by lawinfochina.com, and we retain exclusive copyright over content found on our website except for content we publish as authorized by respective copyright owners or content that is publicly available from government sources.

Due to differences in language, legal systems, and culture, English translations of Chinese law are for reference purposes only. Please use the official Chinese-language versions as the final authority. Lawinfochina.com and its staff will not be directly or indirectly liable for use of materials found on this website.

We welcome your comments and suggestions, which assist us in continuing to improve the quality of our materials as we dynamically expand content.
 
Home | About us | Disclaimer | Chinese